Latest News and Press Releases
Want to stay updated on the latest news?
-
NovalGen appoints Dr Laurent Fischer as Chair of the Board of Directors with immediate effect.
-
TRDA Investors Have Opportunity to Join Entrada Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
-
REPL Investors Have Opportunity to Join Replimune Group, Inc. Fraud Investigation with the Schall Law Firm
-
MONACO CITY, Monaco , May 17, 2026 (GLOBE NEWSWIRE) -- Crypto news today is turning toward AlphaPepe after the project announced that Stage 16 is nearing sell-out while the presale remains live at...
-
MONACO CITY, Monaco, May 17, 2026 (GLOBE NEWSWIRE) -- Crypto news today is turning toward AlphaPepe after the project announced that its presale has raised over $1.25 million while Stage 16 remains...
-
AVITA Medical to host separate investor webinar and Melbourne Q&A event following Q1 2026 results and business updates.
-
Life360 announced that its Board of Directors has authorized management’s deployment of a multi-year share repurchase program of up to $225 million
-
CARLSBAD, Calif., May 17, 2026 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases,...
-
More durable, deeper PSA response in patients treated with Pluvicto plus standard of care (ARPI + ADT) vs. SoC aloneDeep PSA reduction higher in patients receiving Pluvicto combination vs. SoC at 12,...
-
CAPHRA backs WHO concerns on youth nicotine pouch marketing but warns harsh rules could block safer smoking alternatives for adults.